Return to homepagePandemic Pact

Study of the impact of molecular entities on infection by anti-SARS-CoV-2: anti-carbohydrate antibodies, galectins, synthetic glycans and new derivatives of drugs already validated for the treatment of parasitic disease

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    University of São Paulo

  • Principal Investigator

    N/A

  • Research Location

    Brazil

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract